These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8940422)

  • 1. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.
    Mahenthiralingam E; Campbell ME; Henry DA; Speert DP
    J Clin Microbiol; 1996 Dec; 34(12):2914-20. PubMed ID: 8940422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom.
    Clode FE; Kaufmann ME; Malnick H; Pitt TL
    J Clin Microbiol; 2000 May; 38(5):1763-6. PubMed ID: 10790095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis.
    Mahenthiralingam E; Simpson DA; Speert DP
    J Clin Microbiol; 1997 Apr; 35(4):808-16. PubMed ID: 9157133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients.
    Tyler SD; Rozee KR; Johnson WM
    J Clin Microbiol; 1996 Jul; 34(7):1610-6. PubMed ID: 8784555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
    Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
    Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
    J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation.
    McDowell A; Mahenthiralingam E; Dunbar KEA; Moore JE; Crowe M; Elborn JS
    J Med Microbiol; 2004 Jul; 53(Pt 7):663-668. PubMed ID: 15184539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.
    Okazaki M; Watanabe T; Morita K; Higurashi Y; Araki K; Shukuya N; Baba S; Watanabe N; Egami T; Furuya N; Kanamori M; Shimazaki S; Uchimura H
    J Clin Microbiol; 1999 Dec; 37(12):3809-14. PubMed ID: 10565889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.
    Segonds C; Bingen E; Couetdic G; Mathy S; Brahimi N; Marty N; Plesiat P; Michel-Briand Y; Chabanon G
    J Clin Microbiol; 1997 Aug; 35(8):2055-60. PubMed ID: 9230381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
    Speert DP; Henry D; Vandamme P; Corey M; Mahenthiralingam E
    Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic.
    Drevinek P; Vosahlikova S; Cinek O; Vavrova V; Bartosova J; Pohunek P; Mahenthiralingam E
    J Med Microbiol; 2005 Jul; 54(Pt 7):655-659. PubMed ID: 15947430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.
    Coenye T; Spilker T; Martin A; LiPuma JJ
    J Clin Microbiol; 2002 Sep; 40(9):3300-7. PubMed ID: 12202570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis.
    Coenye T; LiPuma JJ
    J Infect Dis; 2002 May; 185(10):1454-62. PubMed ID: 11992281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
    Bernhardt SA; Spilker T; Coffey T; LiPuma JJ
    Clin Infect Dis; 2003 Sep; 37(6):780-5. PubMed ID: 12955638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital.
    Siddiqui AH; Mulligan ME; Mahenthiralingam E; Hebden J; Brewrink J; Qaiyumi S; Johnson JA; LiPuma JJ
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):419-22. PubMed ID: 11583209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.
    Segonds C; Thouverez M; Barthe A; Bossuet-Greif N; Tisseyre L; Plésiat P; Vergnaud G; Chabanon G; Pourcel C
    J Clin Microbiol; 2015 Feb; 53(2):398-409. PubMed ID: 25411181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneity.
    Karpati F; Giedraitis V; Thore M; Lindman R; Monstein HJ; Hjelte L; Jonasson J
    APMIS; 2001 May; 109(5):389-400. PubMed ID: 11478687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.
    Agodi A; Mahenthiralingam E; Barchitta M; Gianninò V; Sciacca A; Stefani S
    J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.